Literature DB >> 9935220

Telomerase components as a diagnostic tool in human oral lesions.

T Sumida1, H Hamakawa, K Sogawa, A Sugita, H Tanioka, N Ueda.   

Abstract

Telomerase activity is considered to be a diagnostic marker of malignancy since most malignant cells express this activity and most somatic cells do not. However, the detection of telomerase activity is rather complicated and is affected by many factors. Recently, human telomerase components were cloned and found to consist of 3 subunits. We assessed which component of telomerase best correlates with malignancy in order to study the possibilities for developing a new diagnostic marker. Telomerase activity was measured by a telomeric repeat amplification protocol (TRAP) assay, and the telomerase components hTR, hTRT-mRNA and TP1-mRNA were detected by the reverse transcriptase-polymerase chain reaction (RT-PCR). Twenty-five of 26 oral malignant lesions, 9 of 22 benign lesions and none of 19 normal control tissues exhibited distinct telomerase activity. hTR and TP1-mRNA expression levels were detected in all malignant lesions and normal control tissues and had no significant correlation with the telomerase activity results. In contrast, hTRT-mRNA expression was closely associated with telomerase activity. All lesions expressing hTRT were telomerase positive. In addition, some samples of dysplastic lesions, benign tumors, lichen planus and normal mucosa exhibiting poor telomerase activity revealed weak expression of hTRT. Expression levels of hTRT-mRNA positively correlated with clinical and pathological findings. Detection of hTRT-mRNA by RT-PCR appeared to be more sensitive for telomerase than measurement of telomerase activity by the TRAP assay. Detection of hTRT-mRNA may provide information useful in the diagnosis of oral malignancies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935220     DOI: 10.1002/(sici)1097-0215(19990105)80:1<1::aid-ijc1>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.

Authors:  C O'Flatharta; M Leader; E Kay; S R Flint; M Toner; W Robertson; M J E M F Mabruk
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 2.  Molecular changes in the multistage pathogenesis of head and neck cancer.

Authors:  Brian J Park; Simion I Chiosea; Jennifer R Grandis
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.

Authors:  Konstantia I Pavlaki; Maria-Christina Kastrinaki; Michail Klontzas; Maria Velegraki; Irene Mavroudi; Helen A Papadaki
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

Review 4.  Clinical implications of biomarkers in head and neck cancer.

Authors:  W M Koch
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

5.  Increased telomerase activity and hTERT expression in human salivary gland carcinomas.

Authors:  Hideo Shigeishi; Masaru Sugiyama; Hidetoshi Tahara; Shigehiro Ono; Ujjal Kumar Bhawal; Masaya Okura; Mikihiko Kogo; Masanori Shinohara; Masanobu Shindoh; Satoru Shintani; Hiroyuki Hamakawa; Takashi Takata; Nobuyuki Kamata
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

6.  Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.

Authors:  J C Soria; L Morat; F Commo; D Dabit; S Perie; L Sabatier; P Fouret
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.